+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Rapid Microbiology Testing Market Size, Share & Trends Analysis Report By Method, By Application , By Product (Instruments , Reagents & Kits, and Consumables), By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 169 Pages
  • April 2024
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5955334
The Europe Rapid Microbiology Testing Market would witness market growth of 10.1% CAGR during the forecast period (2024-2031).

The Germany market dominated the Europe Rapid Microbiology Testing Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $647.8 million by 2031. The UK market is exhibiting a CAGR of 9.1% during (2024 - 2031). Additionally, The France market would experience a CAGR of 11% during (2024 - 2031).



Integrating artificial intelligence (AI) and machine learning (ML) algorithms into the testing platforms revolutionizes data analysis and interpretation. AI-driven software solutions can analyze complex patterns of test results, predict antimicrobial susceptibility profiles, and identify emerging microbial threats with unprecedented speed and accuracy. By harnessing the power of AI and ML, rapid testing technologies can enhance diagnostic accuracy, optimize treatment algorithms, and facilitate real-time decision support for healthcare providers.

Furthermore, multiplexed assays capable of simultaneously detecting multiple pathogens or genetic markers in a single test are gaining prominence in the market. Syndromic panels targeting specific clinical syndromes, such as respiratory infections, gastrointestinal illnesses, or bloodstream infections, enable comprehensive testing for various pathogens associated with specific disease presentations. These multiplexed testing solutions offer enhanced diagnostic yield, streamline laboratory workflows, and improve turnaround times for infectious disease diagnostics.

As per the data from the Government of the United Kingdom, in terms of gross value added (GVA), beverages was the largest manufacturing category with a value of £6.5 billion in 2021. It contributed 21.4% to the total food and drink manufacturing GVA. The other food products category was the second largest, valued at £6.3 billion in the same year, contributing 20.6% to the total food and drink manufacturing GVA. In addition, as per the data from the International Trade Administration, Belgium’s pharmaceutical industry spends $1.64 billion (€1.5 billion) on R&D every year, which is equivalent to 40 percent of all private investment made in Belgium. As a result, Belgium is home to 29 of the world’s top 30 pharmaceutical companies, including important subsidiaries of major U.S. companies such as Johnson & Johnson and Pfizer. Thus, Europe's growing pharmaceutical and food & beverage sectors will drive the expansion of the regional market.

Based on Method, the market is segmented into Growth-based Rapid Microbiology Testing, Cellular Component-based Rapid Microbiology Testing, Nucleic Acid-based Rapid Microbiology Testing, Viability-based Rapid Microbiology Testing and Others. Based on Application, the market is segmented into Industrial Testing (Food & Beverage Testing, Pharmaceutical & Biological Drug Testing, Environmental Testing, Cosmetics & Personal Care Products Testing and Others), Clinical Disease Diagnosis and Research Applications. Based on Product, the market is segmented into Instruments (Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems, Mass Spectrometers, PCR Systems, Bioluminescence & Fluorescence-based Detection Systems, Cytometers, Active Air Samplers and Others), Reagents & Kits, and Consumables. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

List of Key Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Market Report Segmentation

By Method
  • Growth-based Rapid Microbiology Testing
  • Cellular Component-based Rapid Microbiology Testing
  • Nucleic Acid-based Rapid Microbiology Testing
  • Viability-based Rapid Microbiology Testing
  • Others
By Application
  • Industrial Testing
  • Food & Beverage Testing
  • Pharmaceutical & Biological Drug Testing
  • Environmental Testing
  • Cosmetics & Personal Care Products Testing
  • Others
  • Clinical Disease Diagnosis
  • Research Applications
By Product
  • Instruments
  • Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems
  • Mass Spectrometers
  • PCR Systems
  • Bioluminescence & Fluorescence-based Detection Systems
  • Cytometers
  • Active Air Samplers
  • Others
  • Reagents & Kits
  • Consumables
By Country
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Rapid Microbiology Testing Market, by Method
1.4.2 Europe Rapid Microbiology Testing Market, by Application
1.4.3 Europe Rapid Microbiology Testing Market, by Product
1.4.4 Europe Rapid Microbiology Testing Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.2.3 Market Opportunities
3.2.4 Market Challenges
Chapter 4. Competition Analysis - Global
4.1 Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials and Approvals
4.3 Market Share Analysis, 2023
4.4 Top Winning Strategies
4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Aug - 2023, May) Leading Players
4.5 Porter Five Forces Analysis
Chapter 5. Europe Rapid Microbiology Testing Market by Method
5.1 Europe Growth-based Rapid Microbiology Testing Market by Country
5.2 Europe Cellular Component-based Rapid Microbiology Testing Market by Country
5.3 Europe Nucleic Acid-based Rapid Microbiology Testing Market by Country
5.4 Europe Viability-based Rapid Microbiology Testing Market by Country
5.5 Europe Others Market by Country
Chapter 6. Europe Rapid Microbiology Testing Market by Application
6.1 Europe Industrial Testing Market by Country
6.2 Europe Rapid Microbiology Testing Market by Industrial Testing Type
6.2.1 Europe Food & Beverage Testing Market by Country
6.2.2 Europe Pharmaceutical & Biological Drug Testing Market by Country
6.2.3 Europe Environmental Testing Market by Country
6.2.4 Europe Cosmetics & Personal Care Products Testing Market by Country
6.2.5 Europe Others Market by Country
6.3 Europe Clinical Disease Diagnosis Market by Country
6.4 Europe Research Applications Market by Country
Chapter 7. Europe Rapid Microbiology Testing Market by Product
7.1 Europe Instruments Market by Country
7.2 Europe Rapid Microbiology Testing Market by Instruments Type
7.2.1 Europe Automated Microbial Identification & Antimicrobial Susceptibility Testing Systems Market by Country
7.2.2 Europe Mass Spectrometers Market by Country
7.2.3 Europe PCR Systems Market by Country
7.2.4 Europe Bioluminescence & Fluorescence-based Detection Systems Market by Country
7.2.5 Europe Cytometers Market by Country
7.2.6 Europe Active Air Samplers Market by Country
7.2.7 Europe Others Market by Country
7.3 Europe Reagents & Kits Market by Country
7.4 Europe Consumables Market by Country
Chapter 8. Europe Rapid Microbiology Testing Market by Country
8.1 Germany Rapid Microbiology Testing Market
8.1.1 Germany Rapid Microbiology Testing Market by Method
8.1.2 Germany Rapid Microbiology Testing Market by Application
8.1.2.1 Germany Rapid Microbiology Testing Market by Industrial Testing Type
8.1.3 Germany Rapid Microbiology Testing Market by Product
8.1.3.1 Germany Rapid Microbiology Testing Market by Instruments Type
8.2 UK Rapid Microbiology Testing Market
8.2.1 UK Rapid Microbiology Testing Market by Method
8.2.2 UK Rapid Microbiology Testing Market by Application
8.2.2.1 UK Rapid Microbiology Testing Market by Industrial Testing Type
8.2.3 UK Rapid Microbiology Testing Market by Product
8.2.3.1 UK Rapid Microbiology Testing Market by Instruments Type
8.3 France Rapid Microbiology Testing Market
8.3.1 France Rapid Microbiology Testing Market by Method
8.3.2 France Rapid Microbiology Testing Market by Application
8.3.2.1 France Rapid Microbiology Testing Market by Industrial Testing Type
8.3.3 France Rapid Microbiology Testing Market by Product
8.3.3.1 France Rapid Microbiology Testing Market by Instruments Type
8.4 Russia Rapid Microbiology Testing Market
8.4.1 Russia Rapid Microbiology Testing Market by Method
8.4.2 Russia Rapid Microbiology Testing Market by Application
8.4.2.1 Russia Rapid Microbiology Testing Market by Industrial Testing Type
8.4.3 Russia Rapid Microbiology Testing Market by Product
8.4.3.1 Russia Rapid Microbiology Testing Market by Instruments Type
8.5 Spain Rapid Microbiology Testing Market
8.5.1 Spain Rapid Microbiology Testing Market by Method
8.5.2 Spain Rapid Microbiology Testing Market by Application
8.5.2.1 Spain Rapid Microbiology Testing Market by Industrial Testing Type
8.5.3 Spain Rapid Microbiology Testing Market by Product
8.5.3.1 Spain Rapid Microbiology Testing Market by Instruments Type
8.6 Italy Rapid Microbiology Testing Market
8.6.1 Italy Rapid Microbiology Testing Market by Method
8.6.2 Italy Rapid Microbiology Testing Market by Application
8.6.2.1 Italy Rapid Microbiology Testing Market by Industrial Testing Type
8.6.3 Italy Rapid Microbiology Testing Market by Product
8.6.3.1 Italy Rapid Microbiology Testing Market by Instruments Type
8.7 Rest of Europe Rapid Microbiology Testing Market
8.7.1 Rest of Europe Rapid Microbiology Testing Market by Method
8.7.2 Rest of Europe Rapid Microbiology Testing Market by Application
8.7.2.1 Rest of Europe Rapid Microbiology Testing Market by Industrial Testing Type
8.7.3 Rest of Europe Rapid Microbiology Testing Market by Product
8.7.3.1 Rest of Europe Rapid Microbiology Testing Market by Instruments Type
Chapter 9. Company Profiles
9.1 BioMerieux S.A.
9.1.1 Company Overview
9.1.2 Financial Analysis
9.1.3 Segmental and Regional Analysis
9.1.4 Research & Development Expenses
9.1.5 Recent strategies and developments:
9.1.5.1 Acquisition and Mergers:
9.1.6 SWOT Analysis
9.2 QuidelOrtho Corporation
9.2.1 Company Overview
9.2.2 Financial Analysis
9.2.3 Segmental Analysis
9.2.4 Research & Development Expenses
9.2.5 Recent strategies and developments:
9.2.5.1 Trials and Approvals:
9.3 Merck KGaA
9.3.1 Company Overview
9.3.2 Financial Analysis
9.3.3 Segmental and Regional Analysis
9.3.4 Research & Development Expense
9.3.5 SWOT Analysis
9.4 Neogen Corporation
9.4.1 Company Overview
9.4.2 Financial Analysis
9.4.3 Segmental and Regional Analysis
9.4.4 Research & Development Expenses
9.4.5 Recent strategies and developments:
9.4.5.1 Product Launches and Product Expansions:
9.4.6 SWOT Analysis
9.5 Danaher Corporation
9.5.1 Company Overview
9.5.2 Financial Analysis
9.5.3 Segmental and Regional Analysis
9.5.4 Research & Development Expense
9.5.5 Recent strategies and developments:
9.5.5.1 Acquisition and Mergers:
9.5.6 SWOT Analysis
9.6 Abbott Laboratories
9.6.1 Company Overview
9.6.2 Financial Analysis
9.6.3 Segmental and Regional Analysis
9.6.4 Research & Development Expense
9.6.5 Recent strategies and developments:
9.6.5.1 Product launches and Product expansions:
9.6.6 SWOT Analysis
9.7 Thermo Fisher Scientific, Inc.
9.7.1 Company Overview
9.7.2 Financial Analysis
9.7.3 Segmental and Regional Analysis
9.7.4 Research & Development Expenses
9.7.5 Recent strategies and developments:
9.7.5.1 Product Launches and Product Expansions:
9.7.6 SWOT Analysis
9.8 Bruker Corporation
9.8.1 Company Overview
9.8.2 Financial Analysis
9.8.3 Segmental and Regional Analysis
9.8.4 Research & Development Expense
9.8.5 Recent strategies and developments:
9.8.5.1 Product Launches and Product Expansions:
9.8.6 SWOT Analysis
9.9 Charles River Laboratories International, Inc.
9.9.1 Company Overview
9.9.2 Financial Analysis
9.9.3 Segmental and Regional Analysis
9.9.4 SWOT Analysis
9.10. Becton, Dickinson, and Company
9.10.1 Company Overview
9.10.2 Financial Analysis
9.10.3 Segmental and Regional Analysis
9.10.4 Research & Development Expense
9.10.5 Recent strategies and developments:
9.10.5.1 Partnerships, Collaborations, and Agreements:
9.10.6 SWOT Analysis

Companies Mentioned

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Danaher Corporation
  • Abbott Laboratories
  • Thermo Fisher Scientific, Inc.
  • Merck KGaA
  • Bruker Corporation
  • QuidelOrtho Corporation
  • Charles River Laboratories International, Inc.
  • Neogen Corporation

Methodology

Loading
LOADING...